Original Research

Use of the melanoma vaccine in 38 dogs: The South African experience

Joanne L. McLean, Remo G. Lobetti
Journal of the South African Veterinary Association | Vol 86, No 1 | a1246 | DOI: https://doi.org/10.4102/jsava.v86i1.1246 | © 2015 Joanne L. McLean, Remo G. Lobetti | This work is licensed under CC Attribution 4.0
Submitted: 05 November 2014 | Published: 30 April 2015

About the author(s)

Joanne L. McLean, Bryanston Veterinary Hospital, Bryanston, South Africa
Remo G. Lobetti, Bryanston Veterinary Hospital, Bryanston, South Africa

Abstract

The commercially available vaccine Oncept ® is indicated for the management of dogs with stage II or III oral melanoma after local control has been achieved. Survival times in dogs with both oral and digit melanoma have been shown to be significantly increased following vaccination. This retrospective study was designed to document the investigators’ experiences with Oncept ® vaccine when used as an adjunct therapy for treatment of stage II–IV oral, digit and malignant melanoma of other sites after local control had been achieved in dogs presented to a South African specialist referral veterinary practice. Thirty-eight dogs diagnosed with melanoma (25 oral, 6 digit and 7 infiltrative at various other sites) underwent a combination of surgical excision and Oncept ® vaccination. At the end of the study period there were 16 live and 22 dead dogs; median survival time of the live dogs was 29 months (range 2–46 months) versus 8 months (range 2–16 months) for those that died from progressive disease. This study showed that by using a combination of surgical excision and vaccination with Oncept ® survival times in dogs with malignant melanoma of the oral cavity, digit and other sites can be increased significantly.

Keywords

Malignant melanoma, vaccine, dog

Metrics

Total abstract views: 5593
Total article views: 9642

 

Crossref Citations

1. Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs’ Revolution for Immunotherapy
Giuseppina Barutello, Valeria Rolih, Maddalena Arigoni, Lidia Tarone, Laura Conti, Elena Quaglino, Paolo Buracco, Federica Cavallo, Federica Riccardo
International Journal of Molecular Sciences  vol: 19  issue: 3  first page: 799  year: 2018  
doi: 10.3390/ijms19030799

2. A Review of Immunotherapeutic Strategies in Canine Malignant Melanoma
Ramón M. Almela, Agustina Ansón
Veterinary Sciences  vol: 6  issue: 1  first page: 15  year: 2019  
doi: 10.3390/vetsci6010015

3. Potential Promises and Perils of Human Biological Treatments for Immunotherapy in Veterinary Oncology
Jeilene N. Hambly, Carl E. Ruby, Dan V. Mourich, Shay Bracha, Brian P. Dolan
Veterinary Sciences  vol: 10  issue: 5  first page: 336  year: 2023  
doi: 10.3390/vetsci10050336

4. Immunothérapie du cancer
P.J. Bergman
EMC - Vétérinaire  vol: 34  issue: 4  first page: 1  year: 2025  
doi: 10.1016/S1283-0828(25)50493-3

5. A combination of electrochemotherapy, gene electrotransfer of plasmid encoding canine IL-12 and cytoreductive surgery in the treatment of canine oral malignant melanoma
Nina Milevoj, Urša Lampreht Tratar, Ana Nemec, Andreja Brožič, Katarina Žnidar, Gregor Serša, Maja Čemažar, Nataša Tozon
Research in Veterinary Science  vol: 122  first page: 40  year: 2019  
doi: 10.1016/j.rvsc.2018.11.001

6. Treatment of Canine Oral Melanomas: A Critical Review of the Literature
Paolo Pazzi, Gerhard Steenkamp, Anouska J. Rixon
Veterinary Sciences  vol: 9  issue: 5  first page: 196  year: 2022  
doi: 10.3390/vetsci9050196

7. Canine Melanomas as Models for Human Melanomas: Clinical, Histological, and Genetic Comparison
Anaïs Prouteau, Catherine André
Genes  vol: 10  issue: 7  first page: 501  year: 2019  
doi: 10.3390/genes10070501

8. Clinical Trials of Cancer Immunogene Therapies in Companion Animals: An Update (2017–2024)
Gerardo C. Glikin, Liliana M. E. Finocchiaro
Veterinary Sciences  vol: 12  issue: 4  first page: 329  year: 2025  
doi: 10.3390/vetsci12040329

9. Single Amino Acid Deletion at N-Terminus of the Target Antigen in DNA Vaccine Induces Altered CD8+ T Cell Responses against Tumor Antigen
Takashi Imai
Vaccines  vol: 9  issue: 6  first page: 540  year: 2021  
doi: 10.3390/vaccines9060540

10. Metastatic perioral melanoma in a wild mountain gorilla (Gorilla beringei beringei)
Eddy Kambale Syaluha, Dawn Zimmerman, Jan Ramer, Kirsten Gilardi, Martin Kabuyaya, Michael R. Cranfield, Michael S. Kent, Sarah M. Corner, Natasha Yeh, Linda Lowenstine
Journal of Medical Primatology  vol: 50  issue: 3  first page: 197  year: 2021  
doi: 10.1111/jmp.12521

11. Prognostic value of somatic focal amplifications on chromosome 30 in canine oral melanoma
Anais Prouteau, Florian Chocteau, Clotilde de Brito, Edouard Cadieu, Aline Primot, Nadine Botherel, Frédérique Degorce, Laurence Cornevin, Marie A. Lagadic, Florian Cabillic, Pauline de Fornel‐Thibaud, Patrick Devauchelle, Thomas Derrien, Jerome Abadie, Catherine André, Benoît Hédan
Veterinary and Comparative Oncology  vol: 18  issue: 2  first page: 214  year: 2020  
doi: 10.1111/vco.12536

12. The human and animals’ malignant melanoma: comparative tumor models and the role of microbiome in dogs and humans
Catarina Pinto, Catarina Aluai-Cunha, Andreia Santos
Melanoma Research  vol: 33  issue: 2  first page: 87  year: 2023  
doi: 10.1097/CMR.0000000000000880

13. Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020)
Mariateresa Camerino, Davide Giacobino, Luca Manassero, Selina Iussich, Federica Riccardo, Federica Cavallo, Lidia Tarone, Matteo Olimpo, Elena Lardone, Marina Martano, Sara Del Magno, Paolo Buracco, Emanuela Morello
Veterinary and Comparative Oncology  vol: 20  issue: 1  first page: 189  year: 2022  
doi: 10.1111/vco.12761

14. The Use of Oncept Melanoma Vaccine in Veterinary Patients: A Review of the Literature
MacKenzie A. Pellin
Veterinary Sciences  vol: 9  issue: 11  first page: 597  year: 2022  
doi: 10.3390/vetsci9110597

15. Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4‐DNA electrovaccination: A retrospective study on 155 cases
Davide Giacobino, Mariateresa Camerino, Federica Riccardo, Federica Cavallo, Lidia Tarone, Marina Martano, Alfredo Dentini, Selina Iussich, Elena Lardone, Paolo Franci, Alberto Valazza, Luca Manassero, Sara Del Magno, Raffaella De Maria, Emanuela Morello, Paolo Buracco
Veterinary and Comparative Oncology  vol: 19  issue: 4  first page: 651  year: 2021  
doi: 10.1111/vco.12690

16. Histopathologic Diagnoses From Biopsies of the Oral Cavity in 403 Dogs and 73 Cats
Kipp Wingo
Journal of Veterinary Dentistry  vol: 35  issue: 1  first page: 7  year: 2018  
doi: 10.1177/0898756418759760

17. Prolongation of survival of dogs with oral malignant melanoma treated byen blocsurgical resection and adjuvantCSPG4‐antigen electrovaccination
L. A. Piras, F. Riccardo, S. Iussich, L. Maniscalco, F. Gattino, M. Martano, E. Morello, S. Lorda Mayayo, V. Rolih, F. Garavaglia, R. De Maria, E. Lardone, F. Collivignarelli, D. Mignacca, D. Giacobino, S. Ferrone, F. Cavallo, P. Buracco
Veterinary and Comparative Oncology  vol: 15  issue: 3  first page: 996  year: 2017  
doi: 10.1111/vco.12239

18. Recent clinical trials of cancer immunogene therapy in companion animals
Liliana ME Finocchiaro, Gerardo C Glikin
World Journal of Experimental Medicine  vol: 7  issue: 2  first page: 42  year: 2017  
doi: 10.5493/wjem.v7.i2.42

19. DNA vaccines for fish: Review and perspectives on correlates of protection
R A Dalmo
Journal of Fish Diseases  vol: 41  issue: 1  first page: 1  year: 2018  
doi: 10.1111/jfd.12727

20. Survival of dogs with melanoma from a referral veterinary hospital in Japan
Kendy Tzu-yun TENG, Hiroshi OHTA, Tatsuya DEGUCHI, Toshikazu SAKAI, Tsuyoshi KADOSAWA, Himika NUMA, Makoto UKITA, Kohei MAKITA
Journal of Veterinary Medical Science  vol: 88  issue: 4  first page: 624  year: 2026  
doi: 10.1292/jvms.25-0209

21. Clinical impact of butterbur shoot extract in dogs with oral melanoma: a combined phase 1 and 2 clinical trial
Shunsuke Noguchi, Masaru Furuya, Kenji Honda, Ryo Ito, Yukihiro Akao
BMC Veterinary Research  vol: 22  issue: 1  year: 2026  
doi: 10.1186/s12917-026-05326-w

22. Viral protein-based nanoparticles (part 2): Pharmaceutical applications
Rocio Mellid-Carballal, Sara Gutierrez-Gutierrez, Carmen Rivas, Marcos Garcia-Fuentes
European Journal of Pharmaceutical Sciences  vol: 189  first page: 106558  year: 2023  
doi: 10.1016/j.ejps.2023.106558